✦ LIBER ✦

Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United States

✍ Scribed by Stopeck, Alison; Rader, Michael; Henry, David; Danese, Mark; Halperin, Marc; Cong, Ze; Qian, Yi; Dansey, Roger; Chung, Karen

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN116 Cost-Effectiveness of Denosumab V

✍ Lothgren, M.; Bracco, A.; Lucius, B.; Northridge, K.; Halperin, M.; Macarios, D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 60 KB

PCN132 MODELING THE LIFETIME EFFECTIVENE

✍ M.D. Danese; A. Bracco; D. Macarios; K. Chung; A. Barlev; M. Halperin; M. Lothgr 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Denosumab for the Prevention of Skeletal

✍ Maryam Iranikhah; Teresa W. Wilborn; Terri M. Wensel; Jodi B. Ferrell 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

47 COST EFFECTIVENESS OF ZOLEDRONIC ACID

✍ M. Meijboom; M.F. Botteman; S. Kaura 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 504 KB

PCN27 COMPARATIVE BUDGET IMPACT OF FORMU

✍ M.J. Bell; J.D. Miller; M. Namjoshi; M.W. Russell 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

ZOLEDRONIC ACID IS COST EFFECTIVE FOR TH

✍ Meijboom, Marjan; Botteman, Marc F; Kaura, Satyin 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 49 KB